Øgningen i plasmaconcentrationen af rifabutin stammer sandsynligvis fra amprenavirs hæmning af CYP3A4- medieret metabolisme af rifabutin.
The increase in rifabutin plasma concentration is likely to result from inhibition of rifabutin CYP3A4 mediated metabolism by amprenavir.